维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="Engelman L"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Percutaneous dilational tracheostomy in a medical ICU显示文摘	Petros S Engelman L	1997	Intensive CareMed1997，23，：	1
2	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers 显示文摘	Engelman J A Chert L Tan X	2008	Nat Med2008，14，12：	1
3	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
4	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
5	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
6	Airway pressure changes during one - lung ventilation 显示文摘	SZEGEDI L L BARDOCZKY G I ENGELMAN E E	1997	Anesth Analg1997，84，：	1
7	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
8	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	ENGELMAN J A CHEN L TAN X	2008	Nat Med2008，14，12：	1
9	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nature medicine2008，14，12：	1
10	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
11	Effective use of PI3 K and MEK inhibitors to treat mutant Kras G12D and PIK3 CA HI047R murine lung cancers 显示文摘	ENGELMAN JA CHEN L TAN X	2008	Nat Med2008，14，12：	1
12	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
13	Airway pressure changes during one-lung ventilation显示文摘	SZEGEDI L L BARDOCZKYY G I ENGELMAN E E		0，，：	1
14	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
15	The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism显示文摘	ENGELMAN J A LUO J CANTLEY L C	2006	Nat Rev Genet2006，7，：	1
16	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
17	Indirect hemagglutination test for chlamydial antibodies显示文摘	Lewis V J Thacker W L Engelman H M	1972	Appl Microbiol1972，24，1：	1
18	Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women显示文摘	ENGELMAN H M ALEKEL D L HANSON L N		0，，03：	1
19	The evolution of phosphatidylinositol 3-kinases as regulators of growth and me- tabolism 显示文摘	ENGELMAN J A LUO J CANTLEY L C	2006	Nat Rev Genet2006，7，：	1
20	Effective use of PI3K and MEK inhibitors to treat mutant Kxas G12D and PIK3CA H1047R murine lung cancers 显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示